Methods of Detecting Charcot-Marie Tooth Disease Type 2A

Methods are described for screening a subject for risk of Charcot-Marie-Tooth Disease Type 2A or for diagnosing Charcot-Marie-Tooth disease or a predisposition for developing Charcot-Marie-Tooth disease in a subject, by detecting the presence or absence of a mutation in the mitofusin gene in a biological sample collected from the subject. Methods are also described for detecting the presence of a genetic polymorphism associated with Charcot-Marie-Tooth Disease Type 2A in a sample of patient nucleic acid, by amplifying a mitofusin gene sequence in the patient nucleic acid to produce an amplification product; and identifying the presence of a Charcot-Marie-Tooth Disease Type 2A associated polymorphism in the amplification product.

Patents:
US 20,100,184,080

Inventor(s): VANCE JEFFERY M [US]; ZUCHNER STEPHAN [US]; PERICAK-VANCE MARGARET A [US]

Type of Offer: Licensing



Next Patent »
« More Dental Patents

Share on      


CrowdSell Your Patent